| Biotechnology Industry | Healthcare Sector | Ms. Carrie C. Strom CEO | KRX SM Exchange | KR7145020004 ISIN |
| KR Country | 589 Employees | - Last Dividend | 26 Dec 2019 Last Split | - IPO Date |
Hugel, Inc., founded in 2001 and based in Chuncheon-si, South Korea, is a global biopharmaceutical company that specializes in the development, manufacture, and distribution of a wide range of products across various medical and cosmetic categories. The company operates both within South Korea and internationally, underlining its commitment to providing innovative healthcare solutions around the world. With a focus on research and development, Hugel, Inc. continuously strives to advance in biotechnology and medical science, aiming to improve the quality of life for patients globally through its high-quality products.
Hugel, Inc. offers a diverse portfolio of products and services across multiple domains including biopharmaceuticals, cosmetics, and medical devices. The company's groundbreaking work particularly in the area of botulinum toxins and hyaluronic acid fillers has positioned Hugel as a notable player in the global aesthetic medicine market. Below is an overview of their key products and services:
Under brand names such as Botulax, Regenox, Zentox, Reage, Magnion, Hugel Toxin, Juvenlife, Botulim, and Botoshot, Hugel, Inc. offers botulinum toxin products. These products are designed for multiple therapeutic and aesthetic applications such as treatment of essential eyelid convulsion in adults, improvement of glabellar lines, treatment of upper limb spasticity post-stroke, dynamic equinus foot deformity in children with cerebral palsy, and improvement of crow's feet. The botulinum toxin products by Hugel highlight the company's focus on expanding therapeutic indications and enhancing aesthetic outcomes.
The company's hyaluronic acid fillers are marketed under the Dermalax, Hyalsense, Revigance, and The Chaeum brands. These fillers are used for aesthetic purposes such as correcting wrinkles, volumizing facial features, and improving skin hydration and texture. Their high-quality composition ensures safety and efficacy, providing lasting results in skin rejuvenation and aesthetics.
Hugel’s cosmetic line, under the Wellage brand, reflects the company’s commitment to not only medical-grade treatments but also daily skincare. These products leverage cutting-edge biotechnology to provide skincare solutions that aim to improve skin health and appearance, following the same high standards set by their medical devices and therapeutics.
In addition to pharmaceuticals and cosmetics, Hugel, Inc. offers a range of medical devices. These include devices designed to support and enhance the application of their core product offerings, as well as other medical and aesthetic procedures. These devices underscore Hugel's comprehensive approach to cater to the medical aesthetics industry.